Literature DB >> 5450609

Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.

J G Haddad, S J Birge, L V Avioli.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 5450609     DOI： 10.1056/NEJM197009102831101

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

2.  Clinical and biochemical studies of Paget's disease of bone with emphasis on the effects of RNA inhibitors actinomycin D and mithrawycin.

Authors:  J J Fennelly
Journal:  Ir J Med Sci       Date:  1971-10       Impact factor: 1.568

Review 3.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

4.  Effect of calcitonin on carrageenan foot oedema.

Authors:  S E Abdullahi; G De Bastiani; L Nogarin; G P Velo
Journal:  Agents Actions       Date:  1975-10

5.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

6.  Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.

Authors:  J G Haddad; J G Caldwell
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

7.  Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation.

Authors:  J Y Reginster; S Gaspar; R Deroisy; B Zegels; P Franchimont
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

8.  Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits.

Authors:  J Y Reginster; M Azria; S Gaspar; M Bleicher; N Franchimont; M Behhar; A Albert; P Franchimont
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

9.  The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.

Authors:  F Shai; R K Baker; S Wallach
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

10.  Mithramycin therapy in Paget's disease.

Authors:  A S Russell; B C Lentle
Journal:  Can Med Assoc J       Date:  1974-02-16       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.